UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059825
Receipt number R000068413
Scientific Title A single-center prospective observational study on the efficacy of stereotactic body radiotherapy for painful spinal bone metastases
Date of disclosure of the study information 2025/11/19
Last modified on 2025/11/19 13:44:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single-center prospective observational study on the efficacy of stereotactic body radiotherapy for painful spinal bone metastases

Acronym

SpineSBRT

Scientific Title

A single-center prospective observational study on the efficacy of stereotactic body radiotherapy for painful spinal bone metastases

Scientific Title:Acronym

SpineSBRT

Region

Japan


Condition

Condition

Painful spinal bone metastases from malignant tumors

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the pane response and treatment-related toxicity of stereotactic body radiotherapy for painful spinal metastatic lesions from malignant tumors

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Complete pain response rate at 3 months

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients aged 20 years or older at the time of informed consent
2) Patients with an identified primary tumor and a pathological diagnosis of malignancy
3) Patients with painful spinal bone metastases scheduled to undergo stereotactic body radiotherapy
4) Patients whose pain score for the target metastatic lesion is 2 or higher

Key exclusion criteria

Stereotactic body radiotherapy cannot be performed under the current national health insurance system

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Nakamura

Organization

National Cancer Center Hospital East

Division name

Department of Radiation Oncology

Zip code

277-8577

Address

6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan

TEL

0471331111

Email

masanaka@east.ncc.go.jp


Public contact

Name of contact person

1st name Kenji
Middle name
Last name Makita

Organization

National Cancer Center Hospital East

Division name

Department of Radiation Oncology

Zip code

277-8577

Address

6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan

TEL

0471331111

Homepage URL


Email

kemaki3@east.ncc.go.jp


Sponsor or person

Institute

National Cancer Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center Hospital Institutional Review Board

Address

6-5-1,Kashiwanoha,Kashiwa,Chiba,277-8577,Japan

Tel

0471331111

Email

irst@ml.res.ncc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 01 Month 12 Day

Date of IRB

2024 Year 01 Month 12 Day

Anticipated trial start date

2024 Year 01 Month 12 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To evaluate the pain response and treatment-related toxicity of stereotactic body radiotherapy for painful spine metastatic lesions from malignant tumors


Management information

Registered date

2025 Year 11 Month 19 Day

Last modified on

2025 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068413